We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Anthem (ANTM) Q1 Earnings: What's in Store for the Stock?
Read MoreHide Full Article
Anthem Inc. will release first-quarter 2018 results on Apr 25, before the market opens. Last quarter, the company delivered a positive earnings surprise of 3.20%.
Let’s see, how things are shaping up for this announcement.
Anthem’s revenues have been consistently growing over the past several quarters, driven membership growth. The company’s fully insured and self-funded memberships have boosted the total enrollment. The Zacks Consensus Estimate for first-quarter revenues is pegged at $22.5 billion, reflecting a year-over-year rise of nearly 1%.
The company’s Government business has been performing well over a considerable period of time, supported by increasing Medicaid and Medicare enrollment. The consensus mark for total operating revenues of Government business is pegged at $12.8 billion, up 7% year over year.
However, higher medical costs for individual ACA-compliant products and more claims leading to an escalated benefit expense ratio from its Medicaid business are expected to drain the bottom line.
Additionally, continuing with the earlier trend, Anthem is anticipated to have witnessed higher administrative costs in the first quarter.
Anthem’s results are also likely to be affected by a persistent softness in its Individual business.
Earnings Whispers
Our proven model does not conclusively show that Anthem is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESPand a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.
Zacks ESP: Anthem has an Earnings ESP of -1.83%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Anthem carries a Zacks Rank #2, which increases the predictive power of ESP. However, a company needs to have a positive ESP to be confident about an earnings surprise. Thus, this combination leaves surprise prediction inconclusive.
We caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies you may wish to consider from the same space as these have the right combination of elements to beat estimates this time around:
Aetna, Inc. has an Earnings ESP of +0.43% and a Zacks Rank #3. The company is set to report first-quarter earnings on May 1.
Wellcare Health Plans, Inc. has an Earnings ESP of +3.89% and is a Zacks #2 Ranked player. The company is expected to report first-quarter earnings on May 1.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Anthem (ANTM) Q1 Earnings: What's in Store for the Stock?
Anthem Inc. will release first-quarter 2018 results on Apr 25, before the market opens. Last quarter, the company delivered a positive earnings surprise of 3.20%.
Let’s see, how things are shaping up for this announcement.
Anthem’s revenues have been consistently growing over the past several quarters, driven membership growth. The company’s fully insured and self-funded memberships have boosted the total enrollment. The Zacks Consensus Estimate for first-quarter revenues is pegged at $22.5 billion, reflecting a year-over-year rise of nearly 1%.
The company’s Government business has been performing well over a considerable period of time, supported by increasing Medicaid and Medicare enrollment. The consensus mark for total operating revenues of Government business is pegged at $12.8 billion, up 7% year over year.
However, higher medical costs for individual ACA-compliant products and more claims leading to an escalated benefit expense ratio from its Medicaid business are expected to drain the bottom line.
Additionally, continuing with the earlier trend, Anthem is anticipated to have witnessed higher administrative costs in the first quarter.
Anthem’s results are also likely to be affected by a persistent softness in its Individual business.
Earnings Whispers
Our proven model does not conclusively show that Anthem is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESPand a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. But that is not the case here as you will see below.
Zacks ESP: Anthem has an Earnings ESP of -1.83%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Anthem, Inc. Price and EPS Surprise
Anthem, Inc. Price and EPS Surprise | Anthem, Inc. Quote
Zacks Rank: Anthem carries a Zacks Rank #2, which increases the predictive power of ESP. However, a company needs to have a positive ESP to be confident about an earnings surprise. Thus, this combination leaves surprise prediction inconclusive.
We caution against Sell-rated stocks (#4 or 5) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are some companies you may wish to consider from the same space as these have the right combination of elements to beat estimates this time around:
Humana Inc. (HUM - Free Report) is scheduled to report first-quarter earnings on May 2. The company has an Earnings ESP of +0.20% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Aetna, Inc. has an Earnings ESP of +0.43% and a Zacks Rank #3. The company is set to report first-quarter earnings on May 1.
Wellcare Health Plans, Inc. has an Earnings ESP of +3.89% and is a Zacks #2 Ranked player. The company is expected to report first-quarter earnings on May 1.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>